K. Huber
Journal of the American College of Cardiology · 2013–2017
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom K. Huber trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- John K. Kruschke (in Artificial Intelligence)
Papers from K. Huber's perspective
Ordered by how strongly the researchers K. Huber trusts endorse each paper. Same corpus, a different order for every researcher.
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
- Apixaban in patients with atrial fibrillation. (New England Journal of Medicine)
- Bayesian data analysis.
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (Annals of Internal Medicine)
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (European Heart Journal)
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
- Why do patients with atrial fibrillation not receive warfarin? (Archives of Internal Medicine)
- Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based… (Circulation)
- Toward a universal law of generalization for psychological science.
- Discussion of "Analysis of variance--why it is more important than ever" by A. Gelman
Their papers
- 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. (2017) — 947 citations
- Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. (2014) — 1,676 citations
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (2014) — 935 citations
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial (2013) — 625 citations